Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19

Published:2021-01 Issue:1 Volume:113 Page:1129-1140
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Das Gourab,Das Troyee,Chowdhury Nilkanta,Chatterjee Durbadal,Bagchi Angshuman,Ghosh Zhumur

Funder

Council of Scientific and Industrial Research

Department of Science and Technology

Publisher

Elsevier BV

Subject

Genetics

Reference131 articles.

1. Understanding the emerging coronavirus: what it means for health security and infection prevention;Peters;J. Hosp. Infect,2020

2. The SARS-CoV-2 outbreak: what we know;Wu;Int. J. Infect. Dis.,2020

3. SARS-CoV-2: an emerging coronavirus that causes a global threat;Zheng;Int. J. Biol. Sci.,2020

4. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection;Cheng;Clin. Microbiol. Rev.,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates;Pathology - Research and Practice;2024-11

2. Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39;British Journal of Pharmacology;2024-09-03

3. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies;Molecules;2024-02-25

4. Investigation on the Binding Affinity of Five Drug-Like Sulphonamides on SARS-CoV-2 Targets: A computational study;Indian Journal of Chemistry;2024-01-24

5. In silico Docking Analysis of the FDA-Approved Drugs on Envelope Protein of SARS CoV-2 Omicron Variant;Biomedical and Pharmacology Journal;2023-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3